>"However, it does mean that Ebola-Cide will be lowered in its priority".
Yes, and that is fine. May be the market share is not so much for NNVC to go after Ebola.
My concern is that if NNVC starts loosing ground then that unigue nature of NNVC technology IMO looses that glamour. I am sure there are other upstarts and Pharmas working on HIV or FLU, who are we to say that we will not loose ground again?
My suggestion to NNVC would be to get their act together and start publishing some of that work. I do not see any merit in NNVC if all I see is debate on IHUB!
Their work has to be debated and published through peer review.
asif
News 
Market Data 
Discover 
